Atlanta Falcons right tackle Kaleb McGary retired on Wednesday, but it didn't take the team long to find a replacement. The ...
Pricing pressure, fierce competition, and pipeline setbacks are all weighing on Novo Nordisk. The Danish company is less diversified than current and future competitors, and increasingly exposed to ...
Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...
ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk (NOVOb.CO), opens new tab will premiere on Saturday at a theatre outside ...
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...
Novo Nordisk executives project that oral pills could capture more than a third of the total obesity drug market by 2030. Photo: Reuters Earlier this month Danish drugmaker Novo Nordisk launched its ...
Several Indian companies are preparing to launch generic versions of GLP-1 category drug Semaglutide in India ...
By Maggie Fick, Jacob Gronholt-Pedersen and Bhanvi Satija LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a ...
LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost to rival Eli Lilly. Booming ...
The change is being implemented to reflect an increase in streaming revenue, along with changing music consumption behaviors. By Billboard Staff Starting in January, the Billboard charts will add more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results